Company intelligence / Profile preview

Bio360

Sunrise, Florida, USA

Ownership: Private
Development stage: Other

Overview

Bio360 is a consumer healthcare brand specializing in advanced probiotic formulations designed to support various aspects of human health through microbiome modulation. The company offers a range of condition-specific products targeting digestive wellness, immune system support, cognitive function, and skin health. Utilizing clinically studied probiotic strains, Bio360 focuses on delivering high-quality, science-backed supplements to the retail market. The brand is part of the Nutranext portfolio, which is a subsidiary of The Clorox Company, emphasizing a commitment to holistic wellness and microbial science.

Therapeutic areas: GastroenterologyDermatologyNeurologyImmunology
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Food & Nutrition

Beyond the preview

Go deeper on Bio360.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio360.

Explore the full profile